Drugs / Piperacillin/tazobactam
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03262142 Comparator | Jan 2018 → Mar 2023 | Pseudomonas aeruginosa infectious disease, asthma, bronchiectasis, respiratory tract infectious disorder | Chronic Obstructive Pulmonary Disease Trial Network, Denmark | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Piperacillin/tazobactam | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03262142 ↗ |
| Route | Intravenous | “Intravenous Piperacillin/tazobactam four times daily” NCT03262142 ↗ |